New drug EP395 tested for safety in healthy people
NCT ID NCT04819854
First seen Apr 29, 2026 · Last updated May 12, 2026 · Updated 1 time
Summary
This early-stage study tested the safety and tolerability of a new drug called EP395 in 78 healthy adults aged 18 to 65. Participants received single or multiple doses of the drug in capsule form. The goal was to find a safe dose range for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT ALL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Medicines Evaluation Unit (MEU) Ltd.
Manchester, M23 9QZ, United Kingdom
Conditions
Explore the condition pages connected to this study.